Table 1.
Characteristic | All patients n=75,805 n (%) |
Diabetics n=10,317 n (%) |
Non diabetics n=65,488 n (%) |
p value |
---|---|---|---|---|
Male | 46,853 (61.81) | 7,184 (69.63) | 39,669 (60.57) | <.001 |
Age 18–39 | 7,930 (10.46) | 316 (3.06) | 7,614 (11.63) | <.001 |
40–44 | 5,636 (7.43) | 498 (4.83) | 5,138 (7.85) | |
45–49 | 12,474 (16.46) | 1,423 (13.79) | 11,051 (16.87) | |
50–64 | 49,765 (65.65) | 8,080 (78.32) | 41,685 (63.65) | |
Alcoholic liver disease/alcohol abuse | 2,563 (3.38) | 357 (3.46) | 2,206 (3.37) | 0.632 |
Obesity | 3,257 (4.30) | 900 (8.72) | 2,357 (3.60) | <.001 |
HBV | 617 (0.81) | 87 (0.84) | 530 (0.81) | 0.721 |
HIV | 1,571 (2.07) | 153 (1.48) | 1,418 (2.17) | <.001 |
Recent treatment | 16,597 (21.89) | 1,756 (17.02) | 14,841 (22.66) | <.001 |
Cirrhosis | 11,827 (15.60) | 2,341 (22.69) | 9,486 (14.49) | <.001 |
The baseline period was defined as the first 6 months beginning on the date when the chronic hepatitis C definition was met